Key result
Fetal growth restriction is linked to thinner epicardial fat, cardiac dysfunction, and higher adverse perinatal outcomes.
Why the study?
The association between fetal epicardial fat thickness and adverse perinatal outcomes and changes in fetal cardiac function in pregnancies complicated by fetal growth restriction required investigation.
Is fetal epicardial fat thickness associated with fetal cardiac dysfunction and composite adverse perinatal outcomes in pregnancies complicated by fetal growth restriction?
Cohort (n=120)
No
Is fetal epicardial fat thickness associated with fetal cardiac dysfunction and composite adverse perinatal outcomes in pregnancies complicated by fetal growth restriction?
Reduced fetal epicardial fat thickness is associated with impaired fetal cardiac function and higher rates of adverse perinatal outcomes in fetal growth restriction, suggesting its potential utility as a non-invasive risk-stratification marker.
Should not yet change fetal monitoring in growth restriction; hypothesis-generating for epicardial fat as a risk marker.
Objective This study investigates the association between fetal epicardial fat thickness (EFT) and adverse perinatal outcomes in pregnancies complicated by fetal growth restriction (FGR), and assesses changes in fetal cardiac function. Materials and Methods This single‐center, prospective observational study was conducted at a tertiary referral hospital. A total of 120 pregnancies between 28 and 37 weeks of gestation were enrolled: 40 with FGR and 80 healthy controls. EFT, fetal cardiac function parameters, and perinatal outcomes were compared between the FGR and control groups, and the same parameters were compared between the early‐onset and late‐onset FGR subgroups. Receiver operating characteristic analysis was used to evaluate the ability of EFT to discriminate composite adverse perinatal outcome (CAPO). Results Epicardial fat thickness was significantly lower in the FGR group than in controls ( P < 0.001). Among fetal cardiac function parameters, the modified myocardial performance index (Mod‐MPI) and isovolumetric relaxation time were significantly higher in the FGR group ( P = 0.002 and P = 0.001, respectively), whereas ejection time was significantly shorter ( P = 0.013). EFT was significantly lower in early‐onset than in late‐onset FGR ( P < 0.001). Mod‐MPI and isovolumetric contraction time were significantly higher in early‐onset FGR ( P < 0.05 for both). The rate of CAPO was higher in the FGR group ( P < 0.001). Conclusion In this cohort, reduced EFT was associated with FGR and with impaired fetal cardiac function. EFT is a simple, non‐invasive parameter that might help identify FGR pregnancies at increased risk of adverse perinatal outcomes; however, larger multicenter studies are needed to confirm these findings and to validate the proposed cut‐off value.
No takes yet. Share an insight, caveat, or question.
Ağaoğlu et al. (2026) conducted a cohort in Fetal growth restriction (FGR) (n=120). Fetal growth restriction (FGR) and fetal epicardial fat thickness (EFT) assessment vs. Healthy control pregnancies (n=80) was evaluated on Fetal epicardial fat thickness (EFT), fetal cardiac function parameters, and composite adverse perinatal outcome (CAPO) (p=<0.001). Fetal growth restriction was associated with significantly lower epicardial fat thickness (P<0.001), higher modified myocardial performance index (P=0.002), and higher CAPO rates (P<0.001).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: